The goals of the Innate Immune Receptors and Adjuvant Discovery program are to discover, characterize, and support preclinical testing of new adjuvant candidates based upon triggering of the human innate immune system. Adjuvants are defined as molecules that act via innate immune receptors to activate beneficial innate and/or adaptive (T and B cell-mediated) immune responses. Using high throughput screening techniques, investigators will screen compound libraries to identify potential adjuvant products that may be developed as components of antigen specific vaccines against infectious disease, or may serve as stand-alone agents that transiently prevent or treat infectious disease.

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
272200900036C-5-0-1
Application #
8739529
Study Section
Project Start
2009-09-30
Project End
2017-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$3,750,387
Indirect Cost
Name
Corixa Corporation
Department
Type
DUNS #
876218090
City
Hamilton
State
MT
Country
United States
Zip Code
59840